Stay updated on ARO-C3 in Renal Disease Clinical Trial
Sign up to get notified when there's something new on the ARO-C3 in Renal Disease Clinical Trial page.

Latest updates to the ARO-C3 in Renal Disease Clinical Trial page
- Check5 days agoChange DetectedMinor layout and labeling adjustments observed in the new screenshot; no substantive changes to core trial information (design, eligibility, interventions, outcomes, or locations). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check13 days agoNo Change Detected
- Check34 days agoChange DetectedUpdated page status with v3.2.0 and a government-operating notice; removed the IgA glomerulonephritis resource. Overall, it prioritizes operational disclosures over granular content additions.SummaryDifference5%

- Check41 days agoChange DetectedAdd: Revision: v3.1.0 to indicate a new version. Remove: several MedlinePlus topics and an earlier version tag (v3.0.2).SummaryDifference0.6%

- Check56 days agoChange DetectedMinor update: version changed from v3.0.1 to v3.0.2; 'Back to Top' removed.SummaryDifference0.2%

- Check63 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%

- Check70 days agoChange DetectedThe web page has been updated to include specific facility names and locations in South Korea, along with new publications related to IgA glomerulonephritis and drug safety. The previous version's references to kidney diseases and certain location terms have been removed.SummaryDifference9%

Stay in the know with updates to ARO-C3 in Renal Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARO-C3 in Renal Disease Clinical Trial page.